Dapagliflozin found to be safe and effective in elderly patients with heart failure undergoing valve replacement
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...
Minimally invasive valve repair reduces heart failure hospitalizations in patients with severe tricuspid regurgitation
At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...
MassDevice11h
MiRus kicks off Siegel heart valve early feasibility study
MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).
Huntington Beach man meets heart valve engineers who saved his life
Ben McCullough, 76, received an EVOQUE heart valve last fall. On Wednesday, he got to thank the makers face-to-face.
Trilogy valve demonstrates safety and effectiveness in treating aortic regurgitation
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
News Medical on MSN22h
Heart failure patients benefit from dapagliflozin after TAVR procedure
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
The New York Times3d
Using a ‘Tiny Bit of Math’ May Improve Your Heart Health, Study Suggests
Your average daily heart rate is a useful metric; so is your daily step count. Combining the two might be even better. By Matt Richtel Many people use a smartwatch to monitor their cardiovascular ...
Hospital Healthcare Europe4d
Mechanical aortic heart valves favoured for 50-70 age group, study suggests
Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...